YU Lu-shan, BI Hui-chang, WU Bao-jian, GE Guang-bo, ZHENG Jiang, QIAO Hai-ling, ZENG Su. 2018 DMPK research progress in ChinaJ. Acta Pharmaceutica Sinica, 2019,54(6): 963-970. doi: 10.16438/j.0513-4870.2019-0138
Citation: YU Lu-shan, BI Hui-chang, WU Bao-jian, GE Guang-bo, ZHENG Jiang, QIAO Hai-ling, ZENG Su. 2018 DMPK research progress in ChinaJ. Acta Pharmaceutica Sinica, 2019,54(6): 963-970. doi: 10.16438/j.0513-4870.2019-0138

2018 DMPK research progress in China

  • This paper summarizes research progresses of Chinese scholars in the field of drug metabolism and pharmacokinetics (DMPK) in 2018. Chinese scholars focused on drug metabolizing enzymes and transporters, and carried out studies on the mechanisms of drug metabolism and transport of active molecules. Topics of research included regulatory mechanisms of drug metabolizing enzymes or transporters, and their implications in drug development and disease etiology or progression. Here, we summarized studies on drug toxicity based on drug metabolism or transport, rational drug use in the clinic, drug metabolism mediated by intestinal flora, metabolism of traditional Chinese medicines, and new technologies or models in DMPK. In recent years, the research focus of drug metabolism in China has transformed from serving for new drug discovery and rational use, to innovation driven and mechanism oriented research. The domestic research topics and technology utilization are gradually aligning with the international conventions.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return